Every 10th medicine consumed in the world is either counterfeit or substandard (WHO). In India, that problem lies with every 6th medicine. With new-age Pharmaceutical Serialization and Track & Trace technology, the penetration of counterfeit drugs can reduce and patient safety across India and the world will improve.
India stands at a pivotal moment to transform healthcare delivery through technology, much like how UPI revolutionized digital payments. The Ayushman Bharat Digital Mission (ABDM) can address the country’s healthcare challenges by enabling access, affordability, and quality through telemedicine, AI, and digital infrastructure. With limited spending but a massive scale, India can leapfrog traditional models using innovative tools. From managing noncommunicable diseases to tackling specialist shortages, ABDM holds the potential to reimagine care. Though challenges like digital literacy and infrastructure remain, the mission’s success could redefine global health innovation.
The integration of AI into product management and operations is one of the most profound transformations in the business world today. As investors, understanding this shift is critical—not just for staying ahead of the curve but also for capitalizing on emerging opportunities. AI has the potential to redefine how businesses conceptualize, build, and scale products. As the ecosystem matures, early investments in AI-powered product management tools will be the key drivers of growth for the companies of tomorrow.
Everyone’s talking about AI in India - lighting up pitch decks, dominating social media, fueling investment narratives. But where’s the real opportunity to build impactful, sustainable businesses? After 15 years supporting technical founders in India, we’ve seen enough market cycles to spot signals amid the noise. We'll share lessons from several AI investments to guide your focus.
